Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-20-020177
Filing Date
2020-04-30
Accepted
2020-04-30 16:10:08
Documents
2
Effectiveness Date
2020-04-30

Document Format Files

Seq Description Document Type Size
1 DEFA14A torc-defa14a_20200603.htm DEFA14A 38246
2 GRAPHIC gbsrdf4vbeub000001.jpg GRAPHIC 4106
  Complete submission text file 0001564590-20-020177.txt   45065
Mailing Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116 617-482-2333
resTORbio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38359 | Film No.: 20835735
SIC: 2834 Pharmaceutical Preparations